|Slideshows|August 4, 2015

Slide Show: Drug-Resistant Infections and C difficile

The latest CDC Vital Signs includes mathematical modeling that projects increases in drug-resistant infections and Clostridium difficile (C. difficile) without immediate, nationwide improvements in infection control and antibiotic prescribing.

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Latest CME

Video

A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control

Onyema Ogbuagu, MD, FACP, FIDSA; Jeffery A. Goad, PharmD, MPH; William P. Hanage, PhD

Slide Show: Drug-Resistant Infections and C difficile

Related Content

APIC 2026: What Are the Best Ways to Prepare for the CIC Exam? Lessons From a Decade-Long Infection Prevention Study Group

How Dangerous Is Listeria? What Clinicians and Consumers Need to Know About Recent Outbreaks

From Bedside to Biosecurity: Managing Select Agents in Acute Care

How Does a Remote Alaska Hospital Meet Infection Prevention Standards With Limited Resources? Lessons From APIC 2026

Can Hantavirus Spread Between People? What to Know About the Cruise Ship Outbreak and Pandemic Risk